Kim Leitzel

1.3k total citations
55 papers, 791 citations indexed

About

Kim Leitzel is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Kim Leitzel has authored 55 papers receiving a total of 791 indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Oncology, 17 papers in Pulmonary and Respiratory Medicine and 15 papers in Cancer Research. Recurrent topics in Kim Leitzel's work include Bone health and treatments (12 papers), Peptidase Inhibition and Analysis (11 papers) and HER2/EGFR in Cancer Research (10 papers). Kim Leitzel is often cited by papers focused on Bone health and treatments (12 papers), Peptidase Inhibition and Analysis (11 papers) and HER2/EGFR in Cancer Research (10 papers). Kim Leitzel collaborates with scholars based in United States, India and Austria. Kim Leitzel's co-authors include Allan Lipton, Suhail M. Ali, Floyd A. Benko, MICHAEL S. KOPRESKI, Christopher D. Gocke, Emad F. Eskander, Laurence M. Demers, Walter P. Carney, Peter Hamer and Karen Pierce and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Kim Leitzel

54 papers receiving 767 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kim Leitzel United States 16 451 300 294 120 106 55 791
Marjaana Luukkaa Finland 10 344 0.8× 228 0.8× 289 1.0× 164 1.4× 55 0.5× 20 687
Grzegorz Korpanty Canada 15 381 0.8× 244 0.8× 352 1.2× 355 3.0× 122 1.2× 29 1.0k
Akihira Mukaiyama Japan 8 500 1.1× 214 0.7× 196 0.7× 421 3.5× 94 0.9× 10 892
Yasuji Ishimaru Japan 14 241 0.5× 222 0.7× 346 1.2× 204 1.7× 114 1.1× 45 1.1k
Pauline Finlay United Kingdom 12 535 1.2× 261 0.9× 503 1.7× 171 1.4× 75 0.7× 16 1.0k
Hirokazu Amaya Japan 12 369 0.8× 316 1.1× 581 2.0× 242 2.0× 35 0.3× 20 913
Shanna A. Arnold United States 12 334 0.7× 143 0.5× 228 0.8× 96 0.8× 24 0.2× 18 773
Andreas Varkaris United States 17 331 0.7× 253 0.8× 393 1.3× 327 2.7× 70 0.7× 46 836
Bunzo Nakata Japan 16 667 1.5× 254 0.8× 344 1.2× 201 1.7× 86 0.8× 70 977
C Colpaert Belgium 9 345 0.8× 248 0.8× 374 1.3× 95 0.8× 43 0.4× 12 666

Countries citing papers authored by Kim Leitzel

Since Specialization
Citations

This map shows the geographic impact of Kim Leitzel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kim Leitzel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kim Leitzel more than expected).

Fields of papers citing papers by Kim Leitzel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kim Leitzel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kim Leitzel. The network helps show where Kim Leitzel may publish in the future.

Co-authorship network of co-authors of Kim Leitzel

This figure shows the co-authorship network connecting the top 25 collaborators of Kim Leitzel. A scholar is included among the top collaborators of Kim Leitzel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kim Leitzel. Kim Leitzel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
George, Bijesh, Kim Leitzel, Suhail M. Ali, et al.. (2021). Cellular Fitness Phenotypes of Cancer Target Genes from Oncobiology to Cancer Therapeutics. Cells. 10(2). 433–433. 5 indexed citations
2.
Gineyts, Évelyne, Nicolas Bonnet, C. Bertholon, et al.. (2018). The C-Terminal Intact Forms of Periostin (iPTN) Are Surrogate Markers for Osteolytic Lesions in Experimental Breast Cancer Bone Metastasis. Calcified Tissue International. 103(5). 567–580. 9 indexed citations
3.
Lipton, Allan, Kim Leitzel, Suhail M. Ali, et al.. (2018). High turnover of extracellular matrix reflected by specific protein fragments measured in serum is associated with poor outcomes in two metastatic breast cancer cohorts. International Journal of Cancer. 143(11). 3027–3034. 45 indexed citations
4.
Leitzel, Kim, Suhail M. Ali, Lois E. Shepherd, et al.. (2018). Serum PD-L1 and outcomes in CCTG MA.31 phase 3 trial of anti-HER2 therapy in first-line HER2+ metastatic breast cancer patients (trastuzumab arm only).. Journal of Clinical Oncology. 36(15_suppl). 1031–1031. 3 indexed citations
5.
Truica, C., et al.. (2017). Role of the UGT2B17 deletion in exemestane pharmacogenetics. The Pharmacogenomics Journal. 18(2). 295–300. 12 indexed citations
6.
Leitzel, Kim, Suhail M. Ali, Monali Vasekar, et al.. (2016). Serum collagen fragments and outcomes in hormone receptor-positive metastatic breast cancer.. Journal of Clinical Oncology. 34(15_suppl). 539–539. 1 indexed citations
7.
Leitzel, Kim, et al.. (2015). Antiresorptive Therapy in the Management of Cancer Treatment-Induced Bone Loss. Current Osteoporosis Reports. 13(2). 73–77. 12 indexed citations
8.
Ali, Suhail M., et al.. (2013). Plasma MN (carbonic anhydrase IX) and outcome in sunitinib-treated metastatic renal cell cancer.. Journal of Clinical Oncology. 31(6_suppl). 405–405. 1 indexed citations
9.
Alkhateeb, Ahmed, et al.. (2013). Pretreatment serum ferritin and overall survival in metastatic pancreatic cancer.. Journal of Clinical Oncology. 31(4_suppl). 171–171. 1 indexed citations
10.
Lipton, Allan, Wolfgang J. Köstler, Kim Leitzel, et al.. (2010). Quantitative HER2 protein levels predict outcome in fluorescence in situ hybridization‐positive patients with metastatic breast cancer treated with trastuzumab. Cancer. 116(22). 5168–5178. 38 indexed citations
11.
Oh, William, Roberto Vargas, Susanna Jacobus, et al.. (2010). Elevated plasma tissue inhibitor of metalloproteinase‐1 levels predict decreased survival in castration‐resistant prostate cancer patients. Cancer. 117(3). 517–525. 31 indexed citations
12.
Terpos, Evangelos, Meletios Α. Dimopoulos, Vikas Shrivastava, et al.. (2009). High levels of serum TIMP-1 correlate with advanced disease and predict for poor survival in patients with multiple myeloma treated with novel agents. Leukemia Research. 34(3). 399–402. 16 indexed citations
13.
Lipton, Allan, et al.. (2009). Decrease in serum extracellular domain of HER2 at 4 and 8 weeks is associated with prolonged progression-free survival on lapatinib monotherapy.. Cancer Research. 69(2_Supplement). 3140–3140. 4 indexed citations
14.
Lipton, Allan, Suhail M. Ali, Kim Leitzel, et al.. (2007). Elevated plasma tissue inhibitor of metalloproteinase‐1 level predicts decreased response and survival in metastatic breast cancer. Cancer. 109(10). 1933–1939. 40 indexed citations
15.
Almokadem, Salah, Kim Leitzel, Harold A. Harvey, et al.. (2005). Circulating tumor cells in adjuvant breast cancer patients. Journal of Clinical Oncology. 23(16_suppl). 667–667. 4 indexed citations
16.
Clarke, Loren E., Kim Leitzel, Jill P. Smith, Suhail M. Ali, & Allan Lipton. (2003). Epidermal growth factor receptor mRNA in peripheral blood of patients with pancreatic, lung, and colon carcinomas detected by RT-PCR. International Journal of Oncology. 22(2). 425–30. 37 indexed citations
17.
KOPRESKI, MICHAEL S., Floyd A. Benko, Kim Leitzel, et al.. (1997). Detection of mutant K-ras DNA in plasma or serum of patients with colorectal cancer. British Journal of Cancer. 76(10). 1293–1299. 146 indexed citations
18.
Leitzel, Kim, et al.. (1996). Serial serum c-erbB-2 levels in patients with breast carcinoma. Cancer. 78(2). 267–272. 44 indexed citations
19.
Leitzel, Kim, et al.. (1996). Serial serum c‐erbB‐2 levels in patients with breast carcinoma. Cancer. 78(2). 267–272. 1 indexed citations
20.
Leitzel, Kim, et al.. (1982). Failure of nerve growth factor to enhance wound healing in the hamster. Journal of Neuroscience Research. 8(2-3). 413–417. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marjaana Luukkaa Breakdown of academic impact, for papers by Grzegorz Korpanty Breakdown of academic impact, for papers by Akihira Mukaiyama Breakdown of academic impact, for papers by Yasuji Ishimaru Breakdown of academic impact, for papers by Pauline Finlay Breakdown of academic impact, for papers by Hirokazu Amaya Breakdown of academic impact, for papers by Shanna A. Arnold Breakdown of academic impact, for papers by Andreas Varkaris Breakdown of academic impact, for papers by Bunzo Nakata Breakdown of academic impact, for papers by C Colpaert
Rankless by CCL
2026